Stefania-Felicia Barbuceanu

Prof. Dr. Stefania-Felicia Barbuceanu

University of Medicine and Pharmacy "Carol Davila" Bucharest, 050474 Bucharest, Romania
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LSLaura-Ileana Socea
Laura-Ileana Socea
SBStefania-Felicia Barbuceanu
Stefania-Felicia Barbuceanu
PEPahontu Elena
Pahontu Elena
ADAlexandru-Claudiu Dumitru
Alexandru-Claudiu Dumitru
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
TATheodora-Venera Apostol
Theodora-Venera Apostol
Due to the structure of acylhydrazones both by the pharmacophore –CO–NH–N= group and by the different substituents present in the molecules of compounds of this class, various pharmacological activities were reported, including antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory, immunomodulatory, antiedematous, antiglaucomatous, antidiabetic, antioxidant, and actions on the central nervous system and on the cardiovascular system. This fragment is found in the structure of several drugs used in the therapy of some diseases that are at the top of public health problems, like microbial infections and cardiovascular diseases. Moreover, the acylhydrazone moiety is present in the structure of some compounds with possible applications in the treatment of other different pathologies, such as schizophrenia, Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. Considering these aspects, we consider that a study of the literature data regarding the structural and biological properties of these compounds is useful.

12 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
GSGheorghe Stancov
Gheorghe Stancov
OSOana Cristina Seremet
Oana Cristina Seremet
GNGeorgiana Nitulescu
Georgiana Nitulescu
DMDragos Paul Mihai
Dragos Paul Mihai
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
The altered activation or overexpression of protein kinases (PKs) is a major subject of research in oncology and their inhibition using small molecules, protein kinases inhibitors (PKI) is the best available option for the cure of cancer. The pyrazole ring is extensively employed in the field of medicinal chemistry and drug development strategies, playing a vital role as a fundamental framework in the structure of various PKIs. This scaffold holds major importance and is considered a privileged structure based on its synthetic accessibility, drug-like properties, and its versatile bioisosteric replacement function. It has proven to play a key role in many PKI, such as the inhibitors of Akt, Aurora kinases, MAPK, B-raf, JAK, Bcr-Abl, c-Met, PDGFR, FGFRT, and RET. Of the 74 small molecule PKI approved by the US FDA, 8 contain a pyrazole ring: Avapritinib, Asciminib, Crizotinib, Encorafenib, Erdafitinib, Pralsetinib, Pirtobrutinib, and Ruxolitinib. The focus of this review is on the importance of the unfused pyrazole ring within the clinically tested PKI and on the additional required elements of their chemical structures. Related important pyrazole fused scaffolds like indazole, pyrrolo[1,2-b]pyrazole, pyrazolo[4,3-b]pyridine, pyrazolo[1,5-a]pyrimidine, or pyrazolo[3,4-d]pyrimidine are beyond the subject of this work.

Verified
Journal Article
Open access
PDF file
BIBeatrice-Cristina Ivan
Beatrice-Cristina Ivan
SBStefania-Felicia Barbuceanu
Stefania-Felicia Barbuceanu
CHCamelia Mia Hotnog
Camelia Mia Hotnog
AAAdriana Iuliana Anghel
Adriana Iuliana Anghel
Robert AncuceanuRobert Ancuceanu
Robert Ancuceanu
FDFlorea Dumitrascu
Florea Dumitrascu
The current study describes the synthesis, physicochemical characterization and cytotoxicity evaluation of a new series of pyrrole derivatives in order to identify new bioactive molecules. The new pyrroles were obtained by reaction of benzimidazolium bromide derivatives with asymmetrical acetylenes in 1,2-epoxybutane under reflux through the Huisgen [3 + 2] cycloaddition of several ylide intermediates to the corresponding dipolarophiles. The intermediates salts were obtained from corresponding benzimidazole with bromoacetonitrile. The structures of the newly synthesized compounds were confirmed by elemental analysis, spectral techniques (i.e., IR, 1H-NMR and 13C-NMR) and single-crystal X-ray analysis. The cytotoxicity of the synthesized compounds was evaluated on plant cells (i.e., Triticum aestivum L.) and animal cells using aquatic crustaceans (i.e., Artemia franciscana Kellogg and Daphnia magna Straus). The potential antitumor activity of several of the pyrrole derivatives was studied by performing in vitro cytotoxicity assays on human adenocarcinoma-derived cell lines (i.e., LoVo (colon), MCF-7 (breast), and SK-OV-3 (ovary)) and normal human umbilical vein endothelial cells (HUVECs). The obtained results of the cytotoxicity assessment indicated that the tested compounds had nontoxic activity on Triticum aestivum L., while on Artemia franciscana Kellogg nauplii, only compounds 2c and 4c had moderate toxicity. On Daphnia magna, 4b and 4c showed high toxicity; 2a, 2b, and 2c moderate to high toxicity; only 4a and 4d were nontoxic. The compound-mediated cytotoxicity assays showed that several pyrrole compounds demonstrated dose- and time-dependent cytotoxic activity against all tested tumor cell lines, the highest antitumor properties being achieved by 4a and its homologue 4d, especially against LoVo colon cells.

18 January 2025 in Molecules
Verified
Journal Article
Open access
PDF file
SBStefania-Felicia Barbuceanu
Stefania-Felicia Barbuceanu
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
Heterocyclic compounds represent one of the most important classes of natural and synthetic compounds, playing essential roles in various fields, including medicinal chemistry

Verified
Journal Article
Open access
PDF file
BIBeatrice-Cristina Ivan
Beatrice-Cristina Ivan
SBStefania-Felicia Barbuceanu
Stefania-Felicia Barbuceanu
CHCamelia Mia Hotnog
Camelia Mia Hotnog
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
AAAdriana Iuliana Anghel
Adriana Iuliana Anghel
FDFlorea Dumitrascu
Florea Dumitrascu
New pyrrolo[1,2-b]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2H)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, 1H-NMR, 13C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells (Triticum aestivum L.) and crustacean animal cells (Artemia franciscana Kellogg and Daphnia magna Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC50 values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-b]pyridazines 5a and 5c could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for 5a, 2c, and 5f, especially against colon cancer cells.

30 May 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
TATheodora-Venera Apostol
Theodora-Venera Apostol
Carmen ChifiriucCarmen Chifiriuc
Carmen Chifiriuc
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
SBStefania-Felicia Barbuceanu
Stefania-Felicia Barbuceanu
Luminita MarutescuLuminita Marutescu
Luminita Marutescu
In this paper, we report on the antimicrobial activity assessment of 49 compounds previously synthesized as derivatives of alanine or phenylalanine that incorporate a 4-(4-X-phenylsulfonyl)phenyl fragment (X = H, Cl, or Br), namely 21 acyclic compounds (6 × N-acyl-α-amino acids, 1 × N-acyl-α-amino acid ester, and 14 × N-acyl-α-amino ketones) and 28 pentatomic heterocycles from the oxazole-based compound class (6 × 4H-1,3-oxazol-5-ones, 16 × 5-aryl-1,3-oxazoles, and 6 × ethyl 1,3-oxazol-5-yl carbonates). Both in silico and in vitro qualitative and quantitative assays were used to investigate the antimicrobial potential of these derivatives against planktonic and biofilm-embedded microbial strains. Some of the tested compounds showed promising antimicrobial and antibiofilm activity depending on their chemical scaffold and lipophilic character.